| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 17, 2005
Accepted on June 10, 2005
hinge region by SUMO-E3 ligases PIAS1 and PIAS3 regulates ER
transcriptional activity
INSERM Unit 590, Centre Léon Bérard, 69373 Lyon Cedex 08, France
* To whom correspondence should be addressed. E-mail: corbo{at}lyon.fnclcc.fr.
The steroid hormone 17
-estradiol (estrogen) plays a significant role in the normal physiology of the mammary gland and breast cancer development primarily through binding to its receptor, the estrogen receptor
(ER
). ER
is a nuclear transcription factor undergoing different types of post-translational modifications, i.e. phosphorylation, acetylation and ubiquitination, which regulate its transcriptional activation and/or stability. Here we identify ER
as a new target for SUMO-1 modification in intact cells and in vitro. Moreover, ER
sumoylation occurs strictly in the presence of hormone. SUMO-1 appears to regulate ER
-dependent transcription. Using a series of mutants, we demonstrated that ER
is sumoylated at conserved lysine residues within the hinge region. Mutations that prevented SUMO modification impaired ER
-induced transcription without influencing ER
cellular localization. In addition to identifying PIAS1 and PIAS3 as E3 ligases for ER
, we also found that PIAS1 and PIAS3, as well as Ubc9, modulated ER
-dependent transcription independently from their SUMO-1 conjugation activity. These findings identify sumoylation as a new mechanism modulating ER
-dependent cellular response and provide a link between the SUMO and estrogen pathways.
SUMO-1
PIAS1
PIAS3
Ubc9
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
N. B. Berry, M. Fan, and K. P. Nephew Estrogen Receptor-{alpha} Hinge-Region Lysines 302 and 303 Regulate Receptor Degradation by the Proteasome Mol. Endocrinol., July 1, 2008; 22(7): 1535 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Davies, N. Karthikeyan, J. T. Lynch, E.-A. Sial, A. Gkourtsa, C. Demonacos, and M. Krstic-Demonacos Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function Mol. Endocrinol., June 1, 2008; 22(6): 1331 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Tremblay, B. J. Wilson, X.-J. Yang, and V. Giguere Phosphorylation-Dependent Sumoylation Regulates Estrogen-Related Receptor-{alpha} and -{gamma} Transcriptional Activity through a Synergy Control Motif Mol. Endocrinol., March 1, 2008; 22(3): 570 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bawa-Khalfe, J. Cheng, Z. Wang, and E. T. H. Yeh Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells J. Biol. Chem., December 28, 2007; 282(52): 37341 - 37349. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Daniel, E. J. Faivre, and C. A. Lange Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells Mol. Endocrinol., December 1, 2007; 21(12): 2890 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalakonda, S. C. Nallar, D. J. Lindner, J. Hu, S. P. Reddy, and D. V. Kalvakolanu Tumor-Suppressive Activity of the Cell Death Activator GRIM-19 on a Constitutively Active Signal Transducer and Activator of Transcription 3 Cancer Res., July 1, 2007; 67(13): 6212 - 6220. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Heine and J. D. Parvin BRCA1 Control of Steroid Receptor Ubiquitination Sci. Signal., June 19, 2007; 2007(391): pe34 - pe34. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Adams, H. Furneaux, and B. A. White The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-{alpha} (ER{alpha}) and Represses ER{alpha} Messenger RNA and Protein Expression in Breast Cancer Cell Lines Mol. Endocrinol., May 1, 2007; 21(5): 1132 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H. Mascle, D. Germain-Desprez, P. Huynh, P. Estephan, and M. Aubry Sumoylation of the Transcriptional Intermediary Factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger Proteins, Is Required for Its Transcriptional Activity and Is Modulated by the KRAB Domain J. Biol. Chem., April 6, 2007; 282(14): 10190 - 10202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Eakin, M. J. MacCoss, G. L. Finney, and R. E. Klevit Estrogen receptor {alpha} is a putative substrate for the BRCA1 ubiquitin ligase PNAS, April 3, 2007; 104(14): 5794 - 5799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, Y.-S. Kim, X.-P. Yang, M. Albers, M. Koegl, and A. M. Jetten Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor {alpha} Nucleic Acids Res., March 12, 2007; 35(5): 1673 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokota, H. Shibata, I. Kurihara, S. Kobayashi, N. Suda, A. Murai-Takeda, I. Saito, H. Kitagawa, S. Kato, T. Saruta, et al. Coactivation of the N-terminal Transactivation of Mineralocorticoid Receptor by Ubc9 J. Biol. Chem., January 19, 2007; 282(3): 1998 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wu, L. Sun, Y. Zhang, Y. Chen, B. Shi, R. Li, Y. Wang, J. Liang, D. Fan, G. Wu, et al. Coordinated Regulation of AIB1 Transcriptional Activity by Sumoylation and Phosphorylation J. Biol. Chem., August 4, 2006; 281(31): 21848 - 21856. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, E. M. Woo, Y. T. E. Chong, D. R. Homenko, and W. L. Kraus Acetylation of Estrogen Receptor {alpha} by p300 at Lysines 266 and 268 Enhances the Deoxyribonucleic Acid Binding and Transactivation Activities of the Receptor Mol. Endocrinol., July 1, 2006; 20(7): 1479 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Levy, Y.-N. Lee, H. Nechushtan, O. Schueler-Furman, A. Sonnenblick, S. Hacohen, and E. Razin Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3 Blood, April 1, 2006; 107(7): 2839 - 2845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |